Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1998-05-29
2000-04-25
Elliott, George C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
424 9321, 435325, 4353723, 514 9, A61K 3170, A61K 3812, A61K 4800, C12N 510
Patent
active
060544368
ABSTRACT:
We have developed a general procedure for the regulated (inducible) dimerization or oligomerization of intracellular proteins and disclose methods and materials for using that procedure to regulatably initiate cell-specific apoptosis (programmed cell death) in genetically engineered cells.
REFERENCES:
patent: 5171671 (1992-12-01), Evans et al.
Harding et al. (1989) "A Receptor for the Immunosuppressant FK506 is a cis-trans Peptidyl-Prolyl Isomerase" Nature 341, 758.
Schreiber et al. (1991) "Immunophilin-Ligand Complexes as Probes of Intracellular Signaling Pathways" Transplantation Proceedings, 23, 2839.
Schreiber et al. (1992) "Molecular Recognition of Immunophilins and Immunophilin-Ligand Complexes" Tetrahedron 148: 2545-2558.
Schreiber et al. (1991) "Protein Overproduction for Organic Chemists" Tetrahedron, 47, 2543-2562.
Rosen et al. (1992)"Natural Products as Probes of Cellular Function: Studies of Immunophilins" Angew. Chemie, Int. Ed. Eng., 31,384-400.
Bram et al. (1993) "Identification of the Immunophilins Capable of Mediating Inhibition of Signal Transduction by Cyclosphorin A and FK506: Roles of Calcineurin Binding and Cellular Location" Mol. Cell Biol., 13, 4760-4769.
Selvakumaran et al. (1993) "Myeloblastic leukemia cells conditionally blocked by Myc-estrogen receptor chimeric transgenes for terminal differentiation coupled to growth arrest and apoptosis" Blood, 81:2257.
Wandless T.J. (1993) "Turning genes on and off using FKBP and FK506" Doctoral Thesis.
Standaert R.F. (1992) "Biochemical and structural studies of the FK506- and rapamycin-binding proteins (FKBPs)", Abstract of Doctoral Thesis.
Bierer et al. (1990) "Mechanisms of Immunosuppression by FK506: Preservation of T Cell Transmembrane Signal Transduction" Transplantation, 49, 1168.
Rosen et al. (1990) "Inhibition of FKBP Rotamase Activity by Immunosuppressant FK506: A Twisted Amide Surrogate" Science, 248, 863.
Bierer et al. (1990) "Two Distinct Signal Transmission Pathways in T Lymphocytes are Inhibited by Complexes Formed Between an Immunophilin and Either FK506 or Rapamycin" PNAS U.S.A., 87, 9231.
Albers et al. (1990) "Substrate Specificity for the Human Rotamase FKBP: A View of FK506 and Rapamycin as Leucine (twisted amide)-Proline Mimics" J. Org. Chem., 55, 4984.
Bierer et al. (1990) "Probing Immunosuppressant Action with a Nonnatural Immunophilin Ligand" Science, 250, 556.
Schreiber S.L. (1991) "Chemistry and Biology of the Immunophilins and Their Immunosuppressive Ligands" Science, 251, 283.
Fretz et al. (1991) "Rapamycin and FK506 Binding Proteins (Immunophilins)" J. Am. Chem. Soc., 113, 1409.
Beirer et al. (1991) "The Effect of the Immunosuppressant FK506 on Alternate Pathways of T Cell Activation" Eur. J. Immunol., 21, 439-445.
Wandless et al.(1991) "FK506 and Rapamycin Binding to FKBP: Common Elements Involved in Immunophilin-Ligand Complexation" J. Am. Chem. Soc., 113, 2339-2341.
Lane et al. (1991) "Complete Amino Acid Sequence of the FK506 and Rapamycin Binding Protein, FKBP, Isolated from Calf Thymus" J. Prot. Chem., 10, 151-160.
Hultsch et al. (1991) "Inhibition of IgE Receptor-Mediated Exocytosis from Rat Basophilic Leukemia Cells by FK506 is Reversed by Rapamycin: Evidence for Common Signaling Pathways in Mast Cells and T Lymphocytes" FASEB J., 5, A1008 (3705).
Rosen et al. (1991) "Proton and Nitrogen Sequential Assignments and Secondary Structure Determination of the Human FK506 and Rapamycin Binding Protein" Biochemistry, 30, 4774-4789.
Michnick et al. (1991) "Solution Structure of FKBP, a Rotamase Enzyme and Receptor for FK506 and Rapamycin" Science 252, 836-839.
Van Duyne et al. (1991) "Atomic Structure of FKBP-FK506, an Immunophilin-Immunosuppressant Complex" Science, 252, 839-842.
Albers et al. (1991) "FKBP, Thought to Be Identical to PKCI-2, Does Not Inhibit Protein Kinase C" BioMed. Chem. Lett., 1, 205-210.
Albers et al. (1991)"The Relationship of FKBP to PKCI-2" Nature, 351, 527.
Hultsch et al. (1991) "Immunophilin Ligands Demonstrate Common Features of Signal Transduction Leading to Exocytosis or Transcription" PNAS USA., 88, 6229-6233.
Van Duyne et al. (1991) "Atomic Structure of the Rapamycin human immunophilin FKBP-12 complex" J. Am. Chem. Soc., 113, 7433.
Ullman et al. (1991) "Site of action of cyclosporine and FK506 in the pathways of communication between the T-lymhocyte antigen receptor and the early activation genes" Transplant. Proceed., 23, 2845.
Galat et al. (1992) "Rapamycin-Selective 25 kDa Immunophilin" Biochemistry, 31, 2427-2434.
Schreiber et al. (1992) "The Mechanism of Action of Cyclosporin A and FK506" Immunology Today, 13, 136-142.
Liu et al. (1992) "Inhibition of T Cell Signaling by Immunophilin-Ligand Complexes Correlates With Loss of Calcineurin Phosphatase Activity" Biochemistry, 31, 3896-3901.
Francavilla et al. (1992) "Inhibition of Liver, Kidney, and Intestine Regeneration by Rapamycin" Transplantation, 53, 496-498.
Tai et al. (1992) "Association of a 59-Kilodalton Immunophilin with the Glucocorticoid Receptor Complex" Science, 256, 1315-1318.
Schreiber S.L.(1992) "Immunophilin-Sensitive Phosphatase Action in Cell Signaling Pathways" Cell, 70, 365-368.
Kaye et al. (1992) "Effects of Cyclosporin A and FK506 on Fce Receptor type I-Initiated Increases in Cytokine mRNA in Mouse Bone Marrow-Derived Progenito Mast Cells: Resistance to FK506 is Associated with a Deficiency in FKBP12", PNAS USA, 89, 8542-8546.
DiLella et al.(1992) "Chromosomal Band Assignments of the Genes Encoding Human FKBP12 and FKBP13" Biochem. Biophys. Res. Commun., 189, 819-823.
Chung et al. (1992) "Rapamycin-FKBP specifically blocks growth-dependent activation of and signalling by the 70 kd S6 protein kinases" Cell, 69, 1227.
Flanagan et al. (1992) "Intracellular signal transmission: a novel role for the prolyl isomerases" J. Cell. Biochem. Suppl. 0 (16 Part A), 61, Abstract #B005.
Kao et al. (1992) "Nuclear target of cyclosporin A and FK506 action is specifically bound by a heterodimeric protein comprising molecular weights 90K and 45K" J. Cell. Biochem. Suppl. 0 (16 Part B), 239. Abstract #H523.
Flanagan et al. (1992) "Nuclear association of a transcription factor essential for T cell activation by cyclosporin A and FK506" J. Cell. Biochem. Suppl. 0 (16 Part B), 237, Abstract #H514.
Serafini et al. (1992) "Selection and characterization of mutants in a signal transduction/transmission pathway" J. Cell. Biochem. Suppl. 0 (6 Part A) 89, Abstract #B234.
Yang et al. (1993) "A Composite FKBP12-FK506 Surface That Contacts Calcineurin" J. Am. Chem. Soc., 115, 819-820.
Rosen et al. (1993) "Activation of an Inactive Immunophilin by Mutagenesis" J. Am. Chem. Soc., 115, 821-822.
Van Duyne et al. (1993) "Atomic Structures of the Human Immnophilin FKBP12 Complexes with FK506- and Rapamycin" J. Mol. Biol., 229, 105-124.
Tai et al. (1993) "P59 (FK506 Binding Protein 59) Interaction with Heat Shock Proteins is Highly Conserved and May Involve Proteins Other Than Steroid Receptors" Biochemistry, 32, 8842-8847.
Alberg et al. (1993) "Structure-Based Design of a Cyclophilin-Calcineurin Bridging Ligand" Science, 262, 248-250.
Andrus et al. (1993) "Structure-Based Design of an Acyclic Ligand That Bridges FKBP12 and Calcineurin" J. Am. Chem. Soc., 115, 10420-10421.
Albers et al. (1993) "An FKBP-Rapamycin Sensitive, Cyclin-Dependent Kinase Activity That Correlates With the FKBP Rapamycin-Induced G1 Arrest Point in MG-63 Cells" Annals of N. Y. Acad. Sci., 696, 54-62.
Smith et al. (1993) "FKBP54, a Novel FK506 Binding Protein in Avian Progesterone Receptor Complexes and HeLa Extracts" J. Biol. Chem., 268, 24270-24273.
Rudert et al. (1994) "Apoptosis in L929 cells expressing a CD40/Fas chimeric receptor: Dissociation of stimulatory from inhibory death signaling functions" Biochem. Biophys. Res. Comm., 204, 1102.
Ke et al. (1994) "Crystal Structures of Cyclophilin A Complexed with Cyclosporin A and N-methyl-4-[(E)-2-Butenyl]-4,4-Dimethylthreonine Cyclosporin A" Structure, 2, 33-44.
Schultz et al. (1994) "Atomic Structure of the Immunophilin FKBP13-FK506 Complex: Insights Into the Composite Binding Surface for Ca
Belshaw Peter
Crabtree Gerald R.
Schreiber Stuart L.
Spencer David M.
Wandless Thomas J.
Berstein David L.
Board of Trustees of Leland S. Stanford Jr. Univ.
Clauss Isabelle M.
Elliott George C.
Hausdorff Sharon F.
LandOfFree
Regulated apoptosis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Regulated apoptosis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Regulated apoptosis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-993433